STOCK TITAN

Surrozen (SRZN) COO receives stock options and RSU grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Williams Charles O reported acquisition or exercise transactions in this Form 4 filing.

Surrozen, Inc. reported that its Chief Operating Officer, Charles O. Williams, received two new equity awards. On February 17, 2026, he was granted employee stock options covering 102,900 shares of common stock at a grant price of $0.00 per share. These option shares vest over four years in 48 equal monthly installments starting February 1, 2026, conditioned on continued service. He was also granted 102,900 restricted stock units, each representing one share of common stock, which vest in four equal annual installments beginning February 1, 2026, also subject to continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Charles O

(Last) (First) (Middle)
C/O SURROZEN, INC.
171 OYSTER POINT BLVD., SUITE 400

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Surrozen, Inc./DE [ SRZN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $24.53 02/17/2026 A 102,900 (1) 02/16/2036 Common Stock 102,900 $0 102,900 D
Restricted Stock Unit (2) 02/17/2026 A 102,900 (3) (3) Common Stock 102,900 $0 102,900 D
Explanation of Responses:
1. The shares subject to the option award vest over a four-year period in 48 equal monthly installments measured from February 1, 2026, subject to the reporting person's continued service through the applicable vesting date.
2. Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock.
3. The shares subject to the RSUs vest in four equal annual installments starting on February 1, 2026, subject to the reporting person's continued service through the applicable vesting date.
/s/Charles Williams 02/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Surrozen (SRZN) report for Charles O. Williams?

Surrozen reported equity awards to Chief Operating Officer Charles O. Williams. He received 102,900 employee stock options and 102,900 restricted stock units on February 17, 2026, as part of his compensation, all held directly in his name.

How many stock options were granted to Surrozen (SRZN) COO Charles O. Williams?

Charles O. Williams received employee stock options for 102,900 shares of Surrozen common stock. The options were granted at a price of $0.00 per share and vest monthly over four years, beginning on February 1, 2026, subject to his continued service.

What are the vesting terms for the Surrozen (SRZN) COO’s stock options?

The COO’s stock options vest over four years in 48 equal monthly installments. Vesting is measured from February 1, 2026 and requires Charles O. Williams to remain in service through each applicable vesting date to receive the corresponding portion.

How many restricted stock units did Surrozen (SRZN) grant to its COO?

Surrozen granted 102,900 restricted stock units to Chief Operating Officer Charles O. Williams. Each RSU represents a contingent right to receive one share of Surrozen common stock, subject to the award’s vesting and continued service conditions set out in the grant.

What is the vesting schedule for Surrozen (SRZN) restricted stock units granted to the COO?

The RSUs granted to the COO vest in four equal annual installments. Vesting starts on February 1, 2026, with each annual tranche requiring Charles O. Williams to continue serving through the applicable vesting date before shares are delivered.

Do Surrozen (SRZN) restricted stock units each equal one share of common stock?

Yes. Each restricted stock unit granted to the COO represents a contingent right to receive one share of Surrozen’s common stock. Delivery of each share occurs only when the corresponding RSU vests under the award’s schedule and continued service conditions.
Surrozen Inc

NASDAQ:SRZN

SRZN Rankings

SRZN Latest News

SRZN Latest SEC Filings

SRZN Stock Data

230.83M
8.21M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO